NIU

eyevensys

Fort Worth Biotech Eyevensys Completes $30M Series B Funding Round

by | Jan 8, 2020
The startup plans to use the funding to continue developing its technology and to position it as an innovator in ophthalmology. Eyevensys’ tech is a gene therapy platform to deliver ocular drugs via an electrotransfection system to the ciliary muscle of the eye.
MORE